piracetam has been researched along with Cardiac Death in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is an attractive choice of antiepileptic medication because of relatively fewer drug interactions and may be administered through the subcutaneous route." | 2.66 | Levetiracetam at the End of Life: A Case Report and Discussion. ( Clark, K; Mohamudally, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohamudally, A | 1 |
| Clark, K | 1 |
| Sutherland, A | 1 |
| Meldon, C | 1 |
| Harrison, T | 1 |
| Miller, M | 1 |
2 reviews available for piracetam and Cardiac Death
| Article | Year |
|---|---|
Levetiracetam at the End of Life: A Case Report and Discussion.
Topics: Anticonvulsants; Death; Humans; Levetiracetam; Piracetam; Seizures | 2020 |
Subcutaneous Levetiracetam for the Management of Seizures at the End of Life: An Audit and Updated Literature Review.
Topics: Anticonvulsants; Death; Humans; Levetiracetam; Piracetam; Retrospective Studies; Seizures | 2021 |